Lourdes Felix
Amministratore Delegato presso BIOCORRX INC.
Patrimonio netto: 117 791 $ in data 30/04/2024
Posizioni attive di Lourdes Felix
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| BIOCORRX INC. | Direttore/Membro del Consiglio | 07/03/2013 | - |
| Amministratore Delegato | 09/11/2020 | - | |
| Direttore operativo | - | - | |
| Direttore Finanziario/CFO | 01/10/2012 | - | |
| Comptroller/Controller/Auditor | - | 02/03/2020 | |
| Presidente | 26/02/2020 | 09/11/2020 | |
| Treasurer | 01/10/2012 | 17/06/2016 | |
| SIYATA MOBILE INC. | Direttore/Membro del Consiglio | 29/10/2021 | - |
| Independent Dir/Board Member | 29/10/2021 | - | |
| LICHEN CHINA LIMITED | Direttore/Membro del Consiglio | - | - |
| Independent Dir/Board Member | - | - | |
| AVALON GLOBOCARE CORP. | Direttore/Membro del Consiglio | 09/01/2023 | - |
| Independent Dir/Board Member | 09/01/2023 | - | |
| LA ROSA HOLDINGS CORP. | Direttore/Membro del Consiglio | 19/04/2024 | - |
| Independent Dir/Board Member | 19/04/2024 | - | |
BioCorRx Pharmaceuticals, Inc.
 BioCorRx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Part of BioCorRx, Inc., BioCorRx Pharmaceuticals, Inc. is a biopharmaceutical company specializing in developing treatments for substance use disorder. The company is based in Anaheim, CA. The lead candidate is a naltrexone pellet implanted subcutaneously being developed to address both opioid and alcohol use disorders. The company is seeking FDA approval of the naltrexone pellet and exploring other products for regulatory approval. The CEO is Brady James Granier, and the company was founded by Lourdes Felix. | Direttore/Membro del Consiglio | - | - |
| Direttore operativo | - | - | |
| Direttore Finanziario/CFO | - | - | |
| Fondatore | - | - | |
| Presidente | - | - | |
Vocodia Holdings Corp.
 Vocodia Holdings Corp. Packaged SoftwareTechnology Services Vocodia Holdings Corp. engages in the provision of conversational artificial intelligence technology. The firm is also involved in building practical artificial intelligence functions and makes them easily obtainable for businesses on cloud-based platform solutions at low costs and scalable to multiagent vast enterprise solutions. The company was founded by Brian Podolak and James Sposato on April 27, 2021 and is headquartered in Boca Raton, FL. | Direttore/Membro del Consiglio | 22/02/2024 | - |
| Independent Dir/Board Member | 22/02/2024 | - |
Storia della carriera di Lourdes Felix
Formazione di Lourdes Felix
| University of Phoenix | Undergraduate Degree |
| D'Amore-Mckim School of Business | Masters Business Admin |
Statistiche
Distribuzione geografica
| Stati Uniti | 8 |
| Canada | 2 |
| Cina | 2 |
Posizioni
| Director/Board Member | 7 |
| Independent Dir/Board Member | 5 |
| Chief Operating Officer | 2 |
Settori
| Health Technology | 3 |
| Consumer Services | 3 |
| Health Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 6 |
|---|---|
| BIOCORRX INC. | Health Services |
| AVALON GLOBOCARE CORP. | Health Technology |
| SIYATA MOBILE INC. | Electronic Technology |
| LICHEN CHINA LIMITED | Commercial Services |
 | Technology Services |
| LA ROSA HOLDINGS CORP. | Finance |
| Aziende private | 1 |
|---|---|
BioCorRx Pharmaceuticals, Inc.
BioCorRx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Part of BioCorRx, Inc., BioCorRx Pharmaceuticals, Inc. is a biopharmaceutical company specializing in developing treatments for substance use disorder. The company is based in Anaheim, CA. The lead candidate is a naltrexone pellet implanted subcutaneously being developed to address both opioid and alcohol use disorders. The company is seeking FDA approval of the naltrexone pellet and exploring other products for regulatory approval. The CEO is Brady James Granier, and the company was founded by Lourdes Felix. | Health Technology |
- Borsa valori
- Insiders
- Lourdes Felix
- Esperienza